Metformin and the risk of dementia based on an analysis of 396,332 participants

BACKGROUND: AMPK has attracted widespread interest as a potential therapeutic target for age-related diseases, given its key role in controlling energy homeostasis. Metformin (Met) has historically been used to treat Type 2 diabetes and has been shown to counteract age-related diseases. However, stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Shiliang, Zhao, Xingxing, Zhu, Ruifang, Dong, Yongchao, Huang, Lifeng, Zhang, Taiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277541/
https://www.ncbi.nlm.nih.gov/pubmed/35847477
http://dx.doi.org/10.1177/20406223221109454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277541/
https://www.ncbi.nlm.nih.gov/pubmed/35847477
http://dx.doi.org/10.1177/20406223221109454

Ejemplares similares